|
⚲
|
| Keyboard |
| Daniel Chevallard | |
|---|---|
| Firm | |
| Address | c/o Viracta Therapeutics, Inc 2533 S Coast Highway 101, Suite 210 Cardiff, CA 92007 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Viracta Subsidiary Inc | 021-391789 | Executive Officer | 65.0 M of 65.0 M |
||
| Viracta Therapeutics Inc | 021-382883 | Executive Officer | 40.0 M of 40.0 M |
||
| Viracta Therapeutics Inc | 021-352658 | Executive Officer | 16.8 M of 25.0 M |
||
| Regulus Therapeutics Inc | 021-339495 | Executive Officer | 16.7 M of 79.3 M |
||